BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31677902)

  • 1. [Solitary bone plasmocytoma: Experience from the radiotherapy department at Mohammed-V military teaching hospital in Rabat (Morocco)].
    Hadadi K; Hommadi M; Belemlih M; Zaghba N; Maghous A; Marnouch EA; Saghir KA; Elmarjany M; Sifat H; Oukabli M; Mansouri H
    Cancer Radiother; 2019 Dec; 23(8):867-873. PubMed ID: 31677902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solitary plasmocytoma: improvement in critical organs sparing by means of helical tomotherapy.
    Chargari C; Kirova YM; Zefkili S; Caussa L; Amessis M; Dendale R; Campana F; Fourquet A
    Eur J Haematol; 2009 Jul; 83(1):66-71. PubMed ID: 19284417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reossification and prognosis following radiotherapy with/without surgery for spinal solitary plasmacytoma of the bone: a retrospective study of 39 patients.
    Ouyang H; Han S; Jiang L; Zhuang H; Yang S; Liu Y; Zhang L; Liu X; Wei F; Chen K; Zhou S; Liu Z
    Spine J; 2020 Feb; 20(2):283-291. PubMed ID: 31546017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy in the treatment of solitary plasmacytoma.
    Jyothirmayi R; Gangadharan VP; Nair MK; Rajan B
    Br J Radiol; 1997 May; 70(833):511-6. PubMed ID: 9227234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solitary bone plasmocytoma: treatment and outcome features.
    Kochbati L; Ben Romdhane NK; Mrad K; Nasr C; Ben Salah DE; Ben Romdhane K; Maalej M
    Cancer Radiother; 2004 Apr; 8(2):70-4. PubMed ID: 15063873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.
    Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1063-7. PubMed ID: 9719116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy of solitary plasmacytoma.
    Krause S; Hillengass J; Goldschmidt H; Debus J; Neuhof D
    Ann Hematol; 2011 Sep; 90(9):1093-7. PubMed ID: 21336625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solitary plasmacytoma of bone and soft tissue.
    Bolek TW; Marcus RB; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):329-33. PubMed ID: 8892456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary plasmacytoma of bone: treatment, progression, and survival.
    Chak LY; Cox RS; Bostwick DG; Hoppe RT
    J Clin Oncol; 1987 Nov; 5(11):1811-5. PubMed ID: 3681369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy Alone is Associated with Improved Outcomes Over Surgery in the Management of Solitary Plasmacytoma.
    Li QW; Niu SQ; Wang HY; Wen G; Li YY; Xia YF; Zhang YJ
    Asian Pac J Cancer Prev; 2015; 16(9):3741-5. PubMed ID: 25987031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Feasibility Analysis of a Prospective Trial on Stereotactic Body Radiotherapy for Solitary Bone Plasmacytoma.
    Mauro GP; Neffá PP; Villar RC; Martinez GA; de Andrade Carvalho H
    Acta Haematol; 2021; 144(6):627-632. PubMed ID: 34247172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for and results of radiotherapy of plasmacytomas].
    Köst S
    Radiobiol Radiother (Berl); 1990; 31(3):231-7. PubMed ID: 2385745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solitary bone plasmacytoma: management of isolated local relapse following radiotherapy.
    Lewanski CR; Bates T; Bowen J; Ashford RF
    Clin Oncol (R Coll Radiol); 1999; 11(5):348-51. PubMed ID: 10591824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solitary plasmacytoma: experiences from Central Anatolia.
    Coskun HS; Er O; Soyuer S; Altinbas M; Eser B; Karahacioglu E; Altuntas F
    Ir J Med Sci; 2005; 174(1):33-6. PubMed ID: 15868887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study.
    Knobel D; Zouhair A; Tsang RW; Poortmans P; Belkacémi Y; Bolla M; Oner FD; Landmann C; Castelain B; Ozsahin M;
    BMC Cancer; 2006 May; 6():118. PubMed ID: 16677383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
    Wilder RB; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
    Cancer; 2002 Mar; 94(5):1532-7. PubMed ID: 11920511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-institutional analysis of solitary extramedullary plasmacytoma of the head and neck treated with curative radiotherapy.
    Sasaki R; Yasuda K; Abe E; Uchida N; Kawashima M; Uno T; Fujiwara M; Shioyama Y; Kagami Y; Shibamoto Y; Nakata K; Takada Y; Kawabe T; Uehara K; Nibu K; Yamada S
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):626-34. PubMed ID: 21277117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary plasmacytoma of bone and soft tissues.
    Tong D; Griffin TW; Laramore GE; Kurtz JM; Russell AH; Groudine MT; Herron T; Blasko JC; Tesh DW
    Radiology; 1980 Apr; 135(1):195-8. PubMed ID: 7360960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group-Sarcoma Working Party.
    Kilciksiz S; Celik OK; Pak Y; Demiral AN; Pehlivan M; Orhan O; Tokatli F; Agaoglu F; Zincircioglu B; Atasoy BM; Ozseker N; Yersal O; Niang U; Haydaroglu A;
    Am J Hematol; 2008 Sep; 83(9):702-7. PubMed ID: 18543343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metachronous solitary plasmacytoma.
    Khosa R; Seth S; Nangia S
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29054949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.